2029, Licensing and Vaccine - Drug Discovery Digest

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

FDA Law Blog: Biosimilars

DECEMBER 3, 2023

covered insulin product or vaccine). Each phase-in policy allows eligible manufacturers to build up in a stepwise manner to the 10% and 20% applicable discounts by 2029 and 2031, respectively. state pharmaceutical assistance programs). had Part D expenditures on or before August 16, 2022).

Compliance

Compliance Drugs Pharmacy Licensing

Making a “Miracle” HIV Medicine

Codon

FEBRUARY 23, 2025

million new HIV infections by 2029, undermining progress toward the UN’s goal. By 1987, the FDA licensed zidovudine after trials showed it increased survival rates. A lifelong HIV vaccine would be ideal, but developing one has proved difficult. By February, the U.S. Jerome Horwitz and Wolfram Ostertag.

Clinical Trials

Clinical Trials Virus Vaccine Trials

Drug Discovery Digest

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

Making a “Miracle” HIV Medicine

Webinars

Stay Connected